로딩 중…
지수 로딩 중…
Solid Biosciences Inc.
SLDB· NASDAQ· Health Care· Pharmaceuticals, Biotechnology & Life Sciences
$8.33+13.95%
2026-06-18
Price Chart
Solid Biosciences Inc.+79.14%
Financials
※ FY = Fiscal Year
Investment Metrics(as of 2026-06-18)
| Metric | Value |
|---|---|
| Size | |
| Market Cap | $820M |
| Revenue | $0.00 |
| Net Income | $-192M |
| Total Assets | $423M |
| Net Assets | $374M |
| Value | |
| P/B | 2.19x |
| FCF Yield | -21.08% |
| Profitability | |
| ROE | -51.26% |
| ROA | -45.35% |
| Financial Health | |
| Debt Ratio | 13.03% |
| Total Debt | $21M |
| FCF | $-173M |
| Cash | $298M |
| Current Ratio | 13.10x |
| Performance | |
| 1Y Return | 79.14% |
| 1M Return | 37.01% |
| From 52W High | -6.09% |
| 1Y MDD | -44.41% |
| Trading | |
| Volume | 11,078,115 shares |
| Trading Value | $90M |
| Per Share | |
| EPS | $-1.84 |
| BPS | $1.90 |